A rapid internalization of CD74 (106 to 107 molecules/cell/day) in a wide range of cancer cells [53], which is not affected by the binding of the mouse monoclonal anti-CD74 antibody LL1 [54], give rise to several therapeutic approaches. The gene discussed is CD74; the disease is cancer.